Proctitis clinical trials
The registry lists 27 studies for Proctitis across more than 10 countries. 6 are recruiting or about to start. 19 of them are mainly about Proctitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-02.
Get an email when these change. Save the Proctitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Bausch Health Americas, Inc. (3) · Jiangsu Topcel-KH Pharmaceutical Co., Ltd. (2) · Dr. Falk Pharma GmbH (2) · CSA Medical, Inc. (1) · Federal University of Mato Grosso (1) · National Baromedical Services (1) · London North West Healthcare NHS Trust (1) · The University of Western Australia (1)
What is being tested here
Drugs under test in Proctitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Budesonide | 0 | 2 | 3 |
| Mesalamine | 0 | 2 | 2 |
| Tacrolimus | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Association Between Clinical Classification and Prognosis in Chronic Radiation Enteropathy · Sixth Affiliated Hospital, Sun Yat-sen University
Who these studies take
Of the 2 Proctitis studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 27 studies, recruiting or not: 15% stop at 75 or younger and 7% at 65; 15% take children; 0% are for women only and 7% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Association Between Clinical Classification and Prognosis in Chronic Radiation EnteropathyRecruitingNCT073786311 country
- KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal InjuryNot yet recruitingNCT07065175Phase 21 country
- A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic RadiotherapyNot yet recruitingNCT07053761Phase 2
- Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation ProctitisNot yet recruitingNCT06925607Phase 1
- Jianzhong Qushi in Chronic RRINot yet recruitingNCT06837597Phase 3
- Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation ProctitisRecruitingNCT06438809Phase 1/21 country
- Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate SuppositoriesCompletedNCT04469686Phase 323 countries
- The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic ProctosigmoiditisActive, not recruitingNCT070618991 country
- Efficacy of Hyaluronic Acid in Prevention of Acute Radiation ProctitisCompletedNCT06469216Phase 1/21 country
- New Local Treatment of Radiation-induced ProctitisStatus unknownNCT054891071 country
- The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation ProctitisStatus unknownNCT05406882Phase 2/31 country
- Micronized Purified Flavonoid- Fraction (MPFF) in the Management of Radiation ProctitisStatus unknownNCT04335617Phase 31 country
- Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative ProctitisTerminatedNCT01016262Phase 33 countries
- Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01008410Phase 31 country
- Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01008423Phase 31 country
- The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or ProctosigmoiditisTerminatedNCT01349673Phase 31 country
- Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative ProctitisCompletedNCT01966783Phase 21 country
- Faecal Incontinence iNtervention StudyCompletedNCT02355834Not applicable1 country
- Clinical Trial With Mesalamine 1g SuppositoriesTerminatedNCT01172444Phase 31 country
- Rectal Tacrolimus in the Treatment of Resistant Ulcerative ProctitisCompletedNCT01418131Phase 41 country
- Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue InjuriesTerminatedNCT00134628Phase 35 countries
- CryoSpray Ablation(TM)to Determine Safety and Feasibility in Radiation Induced ProctitisWithdrawnNCT00756197Phase 4
- Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative ProctitisCompletedNCT01837615Phase 21 country
- Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis SymptomsCompletedNCT01901042Phase 2/3
- Combined Therapy in Radiation ProctopathyCompletedNCT01613534Phase 41 country
- Budesonide Foam Versus Placebo for Prevention of Acute Radiation ProctitisTerminatedNCT00828230Phase 21 country
- Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.Status unknownNCT01414517Phase 31 country